Fund Holdings — Novo Holdings A/S

Total Portfolio Value
$1.23B
Total Bought
$69.85M
Total Sold
$200.74M
Net Transaction
-$130.89M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
EDGEWISE THERAPEUTICS INC(EWTX)5,350,0005,350,0000132,760168,52513.65%+35,765
XENON PHARMACEUTICALS INC(XENE)0485,438+485,438028,2282.29%+28,228
ENLIVEN THERAPEUTICS INC1,480,0001,280,000-200,00022,79250,1764.07%+27,384
MIRUM PHARMACEUTICALS INC(MIRM)1,264,0281,325,000+60,97299,846122,4049.92%+22,558
MAPLIGHT THERAPEUTICS INC(MPLT)3,686,6223,686,622064,75674,9496.07%+10,194
VAXCYTE INC(PCVX)916,160860,000-56,16042,27249,9754.05%+7,703
4D MOLECULAR THERAPEUTICS IN3,650,7373,650,737027,38133,9882.75%+6,608
ARRIVENT BIOPHARMA INC(AVBP)1,942,1421,942,142039,07644,8053.63%+5,729
CELLDEX THERAPEUTICS INC NEW(CLDX)1,200,0001,200,000032,59238,0643.08%+5,472
ASML HOLDING N V
N Y REGISTRY SHS
113,94694,946-19,000121,906125,40810.16%+3,501
PHARVARIS N V
COM
1,750,0001,750,000048,56349,4384.01%+875
LANZATECH GLOBAL INC(LNZA)158,148158,14802,1762,5320.21%+356
MARQETA INC(MQ)441,558441,55802,0971,8020.15%-296
IO BIOTECH INC(IOBTQ)2,512,4530-2,512,4531,5300—-1,530
BIOMARIN PHARMACEUTICAL INC(BMRN)660,000660,000039,22437,2833.02%-1,940
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)1,961,3172,185,923+224,60624,55619,5641.59%-4,992
APOGEE THERAPEUTICS INC(APGE)570,000450,000-120,00043,02437,8773.07%-5,147
ALIBABA GROUP HLDG LTD(BABA)257,327257,327037,71932,2842.62%-5,435
VALNEVA SE(VALN)2,305,0001,057,421-1,247,57920,3306,6090.54%-13,721
SALESFORCE INC(CRM)330,187393,187+63,00087,47073,3965.95%-14,074
BROOKFIELD CORP(BN)3,496,2453,496,2450160,443141,49311.46%-18,950
CRINETICS PHARMACEUTICALS IN(CRNX)1,625,0001,550,000-75,00075,64456,2964.56%-19,348
INSMED INC(INSM)200,0000-200,00034,8080—-34,808
VIRIDIAN THERAPEUTICS INC(VRDN)2,380,0002,000,000-380,00074,06639,1203.17%-34,946
ZENAS BIOPHARMA INC(ZBIO)1,450,0000-1,450,00052,6500—-52,649
Page 1 of 1
Novo Holdings A/S — 13F Holdings — Q1 2026 | TickerTrail